Influence of physiologic cardiac hypertrophy on the prevalence of heart valve regurgitation

Journal of Ultrasound in Medicine

Volumn 27, Issue 1, 2008, Pages 85-93

  Sandrock, Markus ^c   Schmidt Trucksäß, Arno ^b   Schmitz, Daniel ^d   Niess, Andreas ^c   Dickhuth, Hans Hermann ^a  

^a UNIVERSITY OF FREIBURG   (Germany)

^b TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^c UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

^d UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

Athlete's heart; Prevalence; Regurgitation level; Relative heart volume

Indexed keywords

CARDIOLOGY; DRUG PRODUCTS; POPULATION DYNAMICS; ULTRASONICS;

ATHLETE'S HEART; HEART VALVE REGURGITATION; REGURGITATION LEVELS; RELATIVE HEART VOLUMES;

BIOLOGICAL ORGANS;

ADULT; AORTA VALVE REGURGITATION; ARTICLE; ATHLETE; BICYCLE ERGOMETRY; CARDIORESPIRATORY FITNESS; CONTROLLED STUDY; ECHOCARDIOGRAPHY; ECHOGRAPHY; EXERCISE; EXERCISE TEST; FEMALE; HEART VALVE REGURGITATION; HEART VENTRICLE HYPERTROPHY; HEART VOLUME; HUMAN; MALE; MITRAL VALVE REGURGITATION; NORMAL HUMAN; OXYGEN CONSUMPTION; PHYSIOLOGY; PREVALENCE; PULMONARY VALVE INSUFFICIENCY; TREADMILL; TRICUSPID VALVE REGURGITATION;

EID: 38349098450     PISSN: 02784297     EISSN: None     Source Type: Journal    
DOI: 10.7863/jum.2008.27.1.85     Document Type: Article

References (26)

1. Pelliccia A, Maron BJ. Outer limits of the athlete's heart, the effect of gender, and relevance to the differential diagnosis with primary cardiac diseases. Cardiol Clin 1997; 15:381-396.
2. Keul J, Dickhuth HH, Simon G, Lehmann M. Effect of static and dynamic exercise on heart volume, contractility, and left ventricular dimensions. Circ Res 1981; 48:1162-1170.
3. Dickhuth HH, Nause A, Staiger J, Bonzel T, Keul J. Two-dimensional echocardiographic measurements of left ventricular volume and stroke volume of endurance-trained athletes and untrained subjects. Int J Sports Med 1983; 4:21-26.
4. Fagard RH. Athlete's heart: a meta-analysis of the echocardiographic experience. Int J Sports Med 1996; 17(suppl 3):S140-S144.
5. Fagard RH. Impact of different sports and training on cardiac structure and function. Cardiol Clin 1997; 15:397-412.
6. Pelliccia A, Maron BJ, Spataro A, Proschan MA, Spirito P. The upper limit of physiologic cardiac hypertrophy in highly trained elite athletes. N Engl J Med 1991; 324:295-301.
7. Spirito P, Pelliccia A, Proschan MA, et al. Morphology of the "athlete's heart" assessed by echocardiography in 947 elite athletes representing 27 sports. Am J Cardiol 1994; 74:802-806.
8. Urhausen A, Kindermann W. Ein- und zweidimensionale echokardiographische Herzvolumenbestimmung bei Herzgesunden im Vergleich zur röntgenologischen Methode und zu spiroergometrischen Parametern. Herz Kreislauf 1987; 19:525-528.
9. Scharhag J, Schneider G, Urhausen A, Rochette V, Kramann B, Kindermann W. Athlete's heart: right and left ventricular mass and function in male endurance athletes and untrained individuals determined by magnetic resonance imaging. J Am Coll Cardiol 2002; 40:1856-1863.
10. Helmcke F, Nanda NC, Hsiung MC, et al. Color Doppler assessment of mitral regurgitation with orthogonal planes. Circulation 1987; 75:175-183.
11. Jobic Y, Slama M, Tribouilloy C, et al. Doppler echocardiographic evaluation of valve regurgitation in healthy volunteers. Br Heart J 1993;69:109-113.
12. Klein AL, Burstow DJ, Tajik AJ, et al. Age-related prevalence of valvular regurgitation in normal subjects: a comprehensive color flow examination of 118 volunteers. J Am Soc Echocardiogr 1990; 3:54-63.
13. Yoshida K, Yoshikawa J, Shakudo M, et al. Color Doppler evaluation of valvular regurgitation in normal subjects. Circulation 1988; 78:840-847.
14. Pereira AM, van Thiel SW, Lindner JR, et al. Increased prevalence of regurgitant valvular heart disease in acromegaly. J Clin Endocrinol Metab 2004; 89:71-75.
15. Douglas PS, Berman GO, O'Toole ML, Hiller WD, Reichek N. Prevalence of multivalvular regurgitation in athletes. Am J Cardiol 1989; 64:209-212.
16. Brand A, Dollberg S, Keren A. The prevalence of valvular regurgitation in children with structurally normal hearts: a color Doppler echocardiographic study. Am Heart J 1992; 123:177-180.
17. Biava G, Delfino M, Lagana B, et al. Prevalence of valvular regurgitation in structurally normal hearts: a colour Doppler study. Coron Artery Dis 1997; 8:559-563.
18. Perry GJ, Helmcke F, Nanda NC, Byard C, Soto B. Evaluation of aortic insufficiency by Doppler color flow mapping. J Am Coll Cardiol 1987; 9:952-959.
19. Weissman NJ, Tighe JF Jr, Gottdiener JS, Gwynne JT. An assessment of heart-valve abnormalities in obese patients taking dexfenfluramine, sustained-release dexfenfluramine, or placebo. Sustained-Release Dexfenfluramine Study Group. N Engl J Med 1998; 339:725-732.
20. Akasaka T, Yoshikawa J, Yoshida K, et al. Age-related valvular regurgitation: a study by pulsed Doppler echocardiography. Circulation 1987; 76:262-265.
21. Berger M, Hecht SR, Van Tosh A, Ungarn U. Pulsed and continuous wave Doppler echocardiographic assessment of valvular regurgitation in normal subjects. J Am Coll Cardiol 1989; 13:1540-1545.
22. Kostucki W, Vandenbossche JL, Friart A, Englert M. Pulsed Doppler regurgitant flow patterns of normal valves. Am J Cardiol 1986; 58:309-313.
23. Choong CY, Abascal VM, Weyman J, et al. Prevalence of valvular regurgitation by Doppler echocardiography in patients with structurally normal hearts by two-dimensional echocardiography. Am Heart J 1989; 117:636-642.
24. Rivera JM, Vandervoort PM, Morris E, Weyman AE, Thomas JD. Visual assessment of valvular regurgitation: comparison with quantitative Doppler measurements. J Am Soc Echocardiogr 1994; 7:480-487.
25. US Department of Health and Human Services. Cardiac valvulopathy associated with exposure to fenfluramine or dexfenfluramine: US Department of Health and Human Services interim public health recommendations. MMWR Morb Mortal Wkly Rep 1997.
26. Lonati L, Cuspidi C, Sampieri L, et al. Prevalence of physiological valvular regurgitation in hypertensive patients: echocardiographic and color Doppler study. Cardiology 1992; 81:365-370.